avenzo therapeutics is a startup based in the United States, most recent round Series B, 3 tracked investors.
avenzo therapeutics is a startup founded in 2020 based in the United States. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation oncology therapies for patients. The company’s pipeline includes potential best-in-class small molecules and antibody-drug conjugates (ADCs), with lead candidates targeting cyclin-dependent kinases CDK2 and CDK4, and EGFR/HER3 pathways in solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.